130 related articles for article (PubMed ID: 18344431)
1. In vitro evaluation of radioprotective and radiosensitizing effects of rituximab.
Kapadia NS; Engles JM; Wahl RL
J Nucl Med; 2008 Apr; 49(4):674-8. PubMed ID: 18344431
[TBL] [Abstract][Full Text] [Related]
2. Radiation doses to non-Hodgkin's lymphoma cells and normal bone marrow exposed in vitro. Comparison of an alpha-emitting radioimmunoconjugate and external gamma-irradiation.
Aurlien E; Kvinnsland Y; Larsen RH; Bruland ØS
Int J Radiat Biol; 2002 Feb; 78(2):133-42. PubMed ID: 11779363
[TBL] [Abstract][Full Text] [Related]
3. Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20.
Maddipatla S; Hernandez-Ilizaliturri FJ; Knight J; Czuczman MS
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4556-64. PubMed ID: 17671142
[TBL] [Abstract][Full Text] [Related]
4. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
[TBL] [Abstract][Full Text] [Related]
5. Methylxanthine sensitization of human colon cancer cells to 186Re-labeled monoclonal antibody.
Kinuya S; Yokoyama K; Kudo M; Kasahara Y; Kobayashi K; Motoishi S; Onoma K; Bunko H; Michigishi T; Tonami N
J Nucl Med; 2001 Apr; 42(4):596-600. PubMed ID: 11337548
[TBL] [Abstract][Full Text] [Related]
6. [Apoptosis of human B cell lymphoma Raji cells induced by monovalent anti-CD20 antibody].
Liu YX; Fan DM; Xiong DS; Xu YF; Shao XF; Xu YS; Peng H; Yang M; Qin L; Zhu ZP; Yang CZ
Ai Zheng; 2003 Dec; 22(12):1249-53. PubMed ID: 14693045
[TBL] [Abstract][Full Text] [Related]
7. Characterization of novel murine anti-CD20 monoclonal antibodies and their comparison to 2B8 and c2B8 (rituximab).
Nishida M; Usuda S; Okabe M; Miyakoda H; Komatsu M; Hanaoka H; Teshigawara K; Niwa O
Int J Oncol; 2007 Jul; 31(1):29-40. PubMed ID: 17549402
[TBL] [Abstract][Full Text] [Related]
8. Analysis of changes in CD20, CD55, and CD59 expression on established rituximab-resistant B-lymphoma cell lines.
Takei K; Yamazaki T; Sawada U; Ishizuka H; Aizawa S
Leuk Res; 2006 May; 30(5):625-31. PubMed ID: 16289746
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity of low-dose-rate radioimmunotherapy by the alpha-emitting radioimmunoconjugate Thorium-227-DOTA-rituximab.
Dahle J; Krogh C; Melhus KB; Borrebaek J; Larsen RH; Kvinnsland Y
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):886-95. PubMed ID: 19679402
[TBL] [Abstract][Full Text] [Related]
10. Responses to rituximab vary among follicular lymphoma B cells of different maturation stages.
Mattila AM; Meri S
Scand J Immunol; 2008 Aug; 68(2):159-68. PubMed ID: 18702746
[TBL] [Abstract][Full Text] [Related]
11. Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab.
Carnahan J; Stein R; Qu Z; Hess K; Cesano A; Hansen HJ; Goldenberg DM
Mol Immunol; 2007 Feb; 44(6):1331-41. PubMed ID: 16814387
[TBL] [Abstract][Full Text] [Related]
12. Letrozole sensitizes breast cancer cells to ionizing radiation.
Azria D; Larbouret C; Cunat S; Ozsahin M; Gourgou S; Martineau P; Evans DB; Romieu G; Pujol P; Pèlegrin A
Breast Cancer Res; 2005; 7(1):R156-63. PubMed ID: 15642164
[TBL] [Abstract][Full Text] [Related]
13. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
[TBL] [Abstract][Full Text] [Related]
14. [Radioprotective effect of aloe polysaccharides on three non-tumor cell lines].
Wang ZW; Huang ZS; Yang AP; Li CY; Huang H; Lin X; Liu ZC; Zhu XF
Ai Zheng; 2005 Apr; 24(4):438-42. PubMed ID: 15820066
[TBL] [Abstract][Full Text] [Related]
15. Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.
Mineo JF; Scheffer A; Karkoutly C; Nouvel L; Kerdraon O; Trauet J; Bordron A; Dessaint JP; Labalette M; Berthou C; Labalette P
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4738-45. PubMed ID: 18552383
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and radiosensitization effect of TRA-8 on radioresistant human larynx squamous carcinoma cells.
Wu F; Hu Y; Long J; Zhou YJ; Zhong YH; Liao ZK; Liu SQ; Zhou FX; Zhou YF; Xie CH
Oncol Rep; 2009 Feb; 21(2):461-5. PubMed ID: 19148523
[TBL] [Abstract][Full Text] [Related]
17. Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental study.
Cho H; Koto M; Riesterer O; Molkentine DP; Giri U; Milas L; Story MD; Ha CS; Raju U
Anticancer Res; 2009 Nov; 29(11):4409-15. PubMed ID: 20032386
[TBL] [Abstract][Full Text] [Related]
18. Enhanced anti-tumor immunity generated by Rituximab-coated tumor cell vaccine.
Wang H; Wang D; Li M; Zhou C; Ma W; Su X; Liu R; Zhang S
Cancer Lett; 2008 Sep; 268(1):129-36. PubMed ID: 18468787
[TBL] [Abstract][Full Text] [Related]
19. Radioprotection of human endothelial cells with amifostine.
Andreopoulos D; Schleicher UM; Cotarelo CL; Hand S; Ammon J
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():34-6. PubMed ID: 10584139
[TBL] [Abstract][Full Text] [Related]
20. Curcumin: a new radio-sensitizer of squamous cell carcinoma cells.
Khafif A; Hurst R; Kyker K; Fliss DM; Gil Z; Medina JE
Otolaryngol Head Neck Surg; 2005 Feb; 132(2):317-21. PubMed ID: 15692547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]